Literature DB >> 7930719

Host soluble factors with blocking and stimulating activity on the expression of the bovine leukemia virus.

R O Zandomeni1, E Esteban, M Carrera-Zandomeni, J F Ferrer.   

Abstract

The bovine leukemia virus (BLV), like the human T cell leukemia viruses (HTLV-I and -II), is usually present in its host in a transcriptionally repressed state. However, the viral genome becomes derepressed a few hours after the infected lymphocytes are cultured in vitro. Depending upon the concentrations tested, plasma and lymphatic fluid of BLV-infected cattle have either stimulatory (BSF) or inhibitory (PBB) activity on viral expression in these cultures. These activities can be separated by chromatographic procedures. BSF is either an antiviral antibody or a BLV-induced molecule that binds to IgG. After complete removal of BSF, the PBB activity can be more consistently detected in bovine plasma and lymphatic fluid. PBB activity can also be demonstrated in human plasma. It seems likely that this activity is responsible for the latent state in which BLV, HTLV-I and -II, and human immunodeficiency virus are usually present in their hosts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930719     DOI: 10.1093/infdis/170.4.787

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Purified bovine plasma blocking factor decreases Bovine leukemia virus p24 expression while increasing protein synthesis and transcriptional activity of peripheral blood mononuclear cells in short-term culture.

Authors:  Marianne J van den Heuvel; Barbara J Jefferson; Robert M Jacobs
Journal:  Can J Vet Res       Date:  2005-07       Impact factor: 1.310

2.  Isolation of a bovine plasma fibronectin-containing complex which inhibits the expression of bovine leukemia virus p24.

Authors:  Marianne J van den Heuvel; Barbara J Jefferson; Robert M Jacobs
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Defibrinated bovine plasma inhibits retroviral transcription by blocking p52 activation of the NFkappaB element in the long terminal repeat.

Authors:  Marianne J van den Heuvel; Karen F Copeland; Elizabeth C Cates; Barbara J Jefferson; Robert M Jacobs
Journal:  Can J Vet Res       Date:  2007-04       Impact factor: 1.310

4.  In vivo protein binding and functional analysis of cis-acting elements in the U3 region of the bovine leukemia virus long terminal repeat.

Authors:  J Xiao; G C Buehring
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Latency of viral expression in vivo is not related to CpG methylation in the U3 region and part of the R region of the long terminal repeat of bovine leukemia virus.

Authors:  Shigeru Tajima; Masako Tsukamoto; Yoko Aida
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  A mutant form of the tax protein of bovine leukemia virus (BLV), with enhanced transactivation activity, increases expression and propagation of BLV in vitro but not in vivo.

Authors:  Shigeru Tajima; Masahiko Takahashi; Shin-Nosuke Takeshima; Satoru Konnai; Shan Ai Yin; Shinobu Watarai; Yoshimasa Tanaka; Misao Onuma; Kosuke Okada; Yoko Aida
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.